HPC International Releases Three New Editions of Their Best-selling Book Series Hope & Destiny for Patients with Sickle Cell Disease
Chicago, Illinois, Sept. 06, 2023 (GLOBE NEWSWIRE) -- HPC International , a leading purchased services supplier for healthcare, corporations and academic institutions, has announced the release of three new editions of their best-selling book series, Hope & Destiny, written specifically for patients with sickle cell disease (SCD), an inherited disorder of the red blood cells that disproportionately affects people of color.
- Chicago, Illinois, Sept. 06, 2023 (GLOBE NEWSWIRE) -- HPC International , a leading purchased services supplier for healthcare, corporations and academic institutions, has announced the release of three new editions of their best-selling book series, Hope & Destiny, written specifically for patients with sickle cell disease (SCD), an inherited disorder of the red blood cells that disproportionately affects people of color.
- “HPC International’s vast majority of in-house published books and educational resources are sold to healthcare organizations, which can distribute them directly to patients for free,” said HPC International CEO Hilton M. Hudson, MD, FACS.
- The educational content in the Pinpoint™ app comes from the renowned and best-selling Hope & Destiny book series.
- For more information or to purchase the Hope & Destiny book series, visit HPC International .